Gateway Advisory’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Gateway Advisory’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-12,500	Closed	-$69K	–	44
2014 Q1	$69K	Hold	12,500	–	–	0.03%	41
2013 Q4	$55K	Buy	+12,500	New	+$42.2K	0.03%	41

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Gateway Advisory's CHTP Position: Q2 2014 in Review

Gateway Advisory sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 12,500 shares — an estimated $69K sold.

Gateway Advisory first reported a position in CHTP in Q4 2013 and held it in 2 quarters. The position peaked at $69K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

Gateway Advisory reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
Gateway Advisory sold 12,500 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $69K.
Gateway Advisory first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q4 2013 and held it in 2 quarters.
Gateway Advisory's CHELSEA THERAPEUTICS INT'L LTD position peaked at $69K in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Gateway Advisory's 13F filing for Q2 2014, filed 1 Aug 2014.